Portfolio of Marijuana (Cannabis) Pharma Stocks Traded on the NYSE and NASDAQ
Here is a table of 7 cannabis stocks that are developing cannabis compound medicines.
|7 Cannabis Pharma Stocks|
Stock Returns & Price Chart
Recent Prices &
|Corbus Pharmaceuticals Holdings||CRBP|
|Price data from Quandl as of most recent close.|
stocks are included in the portfolio computations. The current value of the portfolio assumes that $1,428.57 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends.
To inspect the performance of the Cannabis Pharma Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.
The current value of a $10,000 investment is $21,608. The percent return is 116.08%. The annualized return is 29.28%.
|Return Summary for Cannabis Pharma Stocks|
|Current Value of Investment||$21,608.34|
|Number Profitable Returns||506|
|Percent Profitable Returns||75.98%|
|Number Unprofitable Returns||160|
|Percent Unprofitable Returns||24.02%|
|Profitable to Unprofitable Returns Ratio||3.16|
NOTE: The stocks included in the tables and chart are representative of the industry. They are not recommendations.